Skip to main content
SpringerLink
Log in

Screening und Nachsorge des Urothelkarzinoms

Welchen Stellenwert haben Tumormarker?

  • Zum Thema: Urothelkarzinom der Harnblase
  • Published:
Der Urologe B

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Badalament RA (1998) Editorial: Is the role of cystoscopy in the detection of bladder cancer really declining? J Urol 159: 399–400

  2. Johnston B, Morales A, Emerson L, Lundie M (1997) Rapid detection of bladder cancer: a comparative study of point of care tests. J Urol 158: 2098–2101

    Article  CAS  PubMed  Google Scholar 

  3. Leyh H, Hall R, Mazeman E (1998) Wertigkeit von BTA Test und Urinzytologie bei der Diagnosik und Nachsorge des Harnblasenkarzinoms. Akt Ural 29: 57–61

    Article  Google Scholar 

  4. Nunez C, Martinez-Pineiro L, Madrid FJ, Cisnero J, Viguer JW, Martinez-Pineiro JA (1999) Die Wertigkeit des BTA Tests zur Erkennung des Blasenkarzinoms. Akt Urol 30: 112–117

    Article  Google Scholar 

  5. Pode D, Shapiro A, Wald M, Nativ O, Laufer M, Kaver I (1999) Noninvasive detection of bladder cancer with the BTA stat test. J Urol 161: 443–446

    Article  CAS  PubMed  Google Scholar 

  6. Pode D, Golijanin D, Sherman Y, Lebensart R, Shapiro A (1998) Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors. J Urol 159: 389–393

    Article  CAS  PubMed  Google Scholar 

  7. Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, O’Kane DJ (1999) Comparison of screening methods in the detection of bladder cancer. J Urol 161: 388–394

    Article  CAS  PubMed  Google Scholar 

  8. Rathert P, Roth S (1991) Urinzytologie. Praxis und Atlas. 2. Aufl. Springer, Berlin Meidelberg New York

    Book  Google Scholar 

  9. Sheinfeld J, Reuter VE, Melamed MR, Fair WR, Morse M, Sogani PC, Herr HW, Whitmore WF, Cordon-Cardo C (1990) Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. J Urol 143: 285–288

    CAS  PubMed  Google Scholar 

  10. Soloway MS (1999) Editorial: do we have a prostate specific antigen for bladder cancer? J Urol 161: 447–448

    Article  CAS  PubMed  Google Scholar 

  11. Stampfer DS, Carpinito GA, Rodriguez-Villanueva J, Willsey LW, Dinney C, Grossman HB, Fritsche HA, McDougal WS (1998) Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J Urol 159: 394–398

    Article  CAS  PubMed  Google Scholar 

  12. Zippe C, Pandrangi L, Agarwal A (1999) NMP 22 is a sensitive, cost effective test in patients at risk for bladder cancer. J Urol 161: 62–65

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Urologie und Kinderurologie, Klinikum Wuppertal GmbH, Klinikum der Universität Witten/Herdecke, Heusnerstraße 40, D-42283, Wuppertal

    M. Waldner, B. Ubrig & S. Roth

Authors
  1. M. Waldner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Ubrig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Waldner, M., Ubrig, B. & Roth, S. Screening und Nachsorge des Urothelkarzinoms. Der Urologe B 39, 321–324 (1999). https://doi.org/10.1007/s001310050311

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001310050311

Search

Navigation